跳至主要内容
临床试验/ACTRN12621000543886
ACTRN12621000543886招募中2 期

A randomized controlled trial investigating the effect of pre-operative melatonin on the extend of ischemic-reperfusion injury in adult patients undergoing coronary artery bypass grafting (CABG) surgery.

Sir Charles Gairdner Hospital0 个研究点目标入组 114 人开始时间: 2021年5月10日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • 1.Aged between 18 and 90 years.
  • 2.Undergoing elective cardiac surgery, requiring cardiopulmonary bypass (coronary artery bypass grafting (CABG)) at Sir Charles Gairdner Hospital and Saint John of God Subiaco.
  • 3.Being willing and able to provide informed consent.

排除标准

  • Patients will be ineligible for study entry if they have concomitant hepatic failure, an autoimmune disease or the inability to give informed consent. Patients on immunosuppressive drugs, oral contraceptives, fluvoxamine, and those consuming melatonin within two weeks before the operation, will also be excluded.
  • The exclusion criteria further includes patients who are pregnant, breastfeeding, and those requiring urgent or emergency surgery (resulting in insufficient time to take melatonin).

研究者

相似试验